Bausch Health Companies | VRX - Market Capitalization


Bausch Health Companies reported $3.16B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 209.65B 14.21B Aug/2026
ANI Pharmaceuticals USD 1.75B 24M Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bausch Health Companies USD 3.48B 873.55M Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Danaher USD 138.86B 10.4B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.1T 31.24B Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Novo Nordisk A/S DKK 1.03T 373.76B Aug/2026
Pacira USD 1.28B 286M Aug/2026
Perrigo USD 1.45B 135M Aug/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Supernus Pharmaceuticals USD 2.52B 181M Aug/2026
Vertex Pharmaceuticals USD 121.59B 4.48B Aug/2026
Zoetis USD 49.71B 5.74B Mar/2026